Halitosis

This page is general patient information and does not replace an individual medical or dental assessment, diagnosis or recommendation.

Definition and scope

Halitosis means an unpleasant odour in exhaled air. Most persistent, objectively verified cases originate in the oral cavity, where bacterial breakdown of proteins can produce volatile sulphur compounds (VSCs). Other odorants and less common extra-oral conditions may contribute. A gas measurement alone cannot establish the diagnosis or cause.^[1],[2]

Prevalence estimates vary considerably between studies and methods, but several reports suggest that a substantial proportion of the adult population experiences persistent bad breath at some point.^[2],[10] The relevant odorants include volatile sulphur compounds (VSCs) — primarily hydrogen sulphide (H₂S), methyl mercaptan (CH₃SH) and dimethyl sulphide ((CH₃)₂S) — formed by anaerobic proteolysis of the sulphur-containing amino acids cysteine and methionine.^[1],[3],[12] EndoCap takes as its starting point the consensus framework set out in the Clinical Practice Guidelines on the Diagnosis and Treatment of Halitosis (International Dental Journal, 2026) — a consensus framework, not a formal GRADE-based guideline — together with the international consensus published in J Breath Res (2014) and EFP's public-awareness materials (2025).^[1],[2],[3]

Most cases of persistent bad breath originate in the mouth, for example tongue coating, gum disease, dry mouth or dental problems. Assessment should therefore start with an evaluation of the mouth and teeth. Where relevant, an ENT assessment or a targeted medical work-up may be appropriate.

When bad breath is objectively confirmed without a likely cause in the mouth or the ENT area, a targeted medical assessment may be relevant. Gastrointestinal assessment is only carried out when symptoms, medical history or clinical findings give an independent suspicion of gastrointestinal disease.

Pathophysiology: how does the odour arise?

The oral microbiome contains more than 700 bacterial taxa. When oxygen tension falls — for example in deep periodontal pockets (< 3 mmHg O₂), in tonsillar crypts or under thick tongue coating — the biofilm shifts from a saccharolytic to a proteolytic metabolism. Gram-negative anaerobes hydrolyse peptides and release free sulphur amino acids, after which the enzymes cystathionine-β-lyase and methionine-γ-lyase convert cysteine to H₂S and methionine to CH₃SH.^[12],[13]

• Hydrogen sulphide (H₂S) — "rotten egg" odour; often seen with tongue coating and insufficient oral hygiene.^[1],[12]
• Methyl mercaptan (CH₃SH) — "rotting cabbage"; can be seen with periodontal disease, but the level or ratio to other gases cannot alone establish or rule out a diagnosis.^[1],[6],[12]
• Dimethyl sulphide ((CH₃)₂S) — sweetish sulphur note; can occur in blood-borne extraoral halitosis, but requires an independent medical work-up to establish any underlying cause.^[7]
• Secondary metabolites — short-chain fatty acids (butyric, valeric, propionic acid), the diamines cadaverine and putrescine, indole and skatole can contribute to the odour profile.^[12],[15]

OralChroma measures selected volatile sulphur compounds in exhaled breath. The result can help characterise the odour profile and follow changes over time, but cannot on its own establish the cause or the anatomical origin. It must be interpreted together with the medical history, an oral and dental examination and, where relevant, a calibrated organoleptic assessment.^[1],[3]

Classification

The international consensus divides halitosis into three main categories based on clinical objectivity and underlying pathology.^{[1],[3],[4],[5],[11]}

I. Genuine halitosis

Genuine halitosis is present when persistent odour can be verified by a relevant clinical assessment. There is no single universal instrumental threshold that can alone diagnose all forms of halitosis.

• Physiological halitosis — transient odour without underlying disease. The classic example is "morning breath" due to reduced salivary flow during sleep with transient bacterial putrefaction, as well as short-lived diet-related odours (garlic, onion, spices, alcohol).^[3],[5]
• Pathological halitosis — persistent odour caused by structural or microbiological disease. Divided by anatomical origin:
  • Intraoral pathological — the large majority of persistent cases have an intraoral basis.^[1],[2],[6]
  • Extraoral pathological — less common; airway, upper GI or systemic-metabolic origin.^[1],[7]

II. Pseudo-halitosis

The patient is convinced of having bad breath, but objective measurements (organoleptic and instrumental) show no odour. Relevant information about the findings, review of measurement data and targeted clinical counselling can help some patients, but insight and course vary, and the condition must not be established on the basis of a negative gas measurement alone.^[1],[3],[4]

III. Olfactory reference disorder (ORD/halitophobia)

If concern about body odour persists despite repeated relevant assessments without objective findings, and causes significant distress or functional impairment, olfactory reference disorder may be one explanation. Insight can vary — some patients have partial or good insight, others do not. The condition must not be diagnosed on the basis of a negative gas measurement alone. Patients should be met empathetically and offered relevant medical or psychological/psychiatric assessment.^[1],[3],[4]

Aetiology: direct vs. indirect causes

Direct causes — the source of the odour

Direct causes comprise the biological substrates and microbial processes that directly generate VSC.^[1],[12]

• Tongue-coating proteolysis: The posterior third of the tongue dorsum functions as the principal reservoir of desquamated epithelial cells, blood cells and food debris. Anaerobic bacteria — including Prevotella intermedia and Treponema denticola — break down cysteine and methionine into VSC.^{[6],[12],[13]}
• Periodontal disease activity: Advanced gingivitis and periodontitis expand the subgingival anaerobic niche. "Red Complex" pathogens (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola) drive collagen breakdown, whose products the bacteria subsequently use as substrate for further VSC production.^[1],[6],[14]
• Systemic, blood-borne exhalation: Metabolic conditions introduce volatile substances into the bloodstream, which cross the alveolar membrane and are excreted via the lungs:^[7]
  • Diabetic ketoacidosis — acetone (sweetish/fruity odour).
  • End-stage renal failure — dimethylamine and trimethylamine (uraemic, ammonia-like).
  • Hepatic cirrhosis — pulmonary excretion of sulphur compounds (foetor hepaticus).

Indirect causes — structural and environmental triggers

Indirect causes do not themselves produce VSC, but create the micro-environments that allow anaerobic bacteria to thrive.^[1],[15]

• Anatomical pockets and retentive factors: Non-vital pulp, open root canals, ill-fitting dentures and tonsilloliths (in deep tonsillar crypts) act as structural traps that protect food debris and bacteria from the mechanical clearance of saliva.^[15]
• Hyposalivation (xerostomia): Saliva is the mouth's primary defence, with antimicrobial enzymes and mechanical clearance. Sjögren's syndrome, mouth breathing and xerostomia-inducing medication remove this protection and promote rapid anaerobic overgrowth.^[13],[15]

Medical assessment on independent suspicion: Conditions such as gastroesophageal reflux (GERD), hiatal hernia, SIBO or erosive oesophagitis are not part of the routine assessment of halitosis and are not, on their own, regarded as a documented cause. A targeted medical or gastrointestinal assessment is carried out only when symptoms, medical history or clinical findings give an independent clinical suspicion of gastrointestinal disease.^[15]

Evidence-based diagnostic workflow

The modern approach moves from the patient's subjective complaint to a clinical assessment in which a calibrated organoleptic assessment is the central method. Where needed, this is supplemented with instrumental measurements such as gas chromatography (OralChroma) or portable sulphide monitoring.^[1],[3]

1. Organoleptic scoring (OLS)

Despite technological advances, OLS remains the clinical reference standard. A calibrated clinician smells exhaled breath via a short tube or at approximately 20 cm distance and scores on the standardised 0–5 scale:^{[1],[3],[5],[8]}

• 0 — no odour.
• 1 — barely noticeable odour.
• 2 — slight but clearly noticeable odour.
• 3 — moderate odour.
• 4 — strong odour.
• 5 — overwhelming, severe malodour.

Preparation: Recent use of antibiotics, mouthwash, smoking, food and oral hygiene can all affect the result. Follow the clinic's specific preparation instructions and tell us about your medication. Never stop prescribed medication or antibiotics without agreement with your treating doctor.^[3]

2. Gas chromatography (GC)

An objective instrument that supplements the organoleptic assessment. A breath sample from the mouth is analysed with a clinical gas chromatograph that isolates and measures individual VSC in parts per billion (ppb). The result can help characterise the odour profile, but cannot on its own establish the cause or anatomical origin — it must be interpreted together with the medical history and clinical examination.^[1],[3],[7]

Odour-character descriptions — informative, not diagnostic

Descriptions such as "sweetish", "fishy", "faecal" or "acetone-like" breath are non-specific observations. They cannot on their own be used to diagnose diabetes, liver, kidney or bowel disease, and must always be followed up with an independent clinical assessment before such a cause can be confirmed or excluded.^[7]

3. Electrochemical VSC monitors (e.g. Halimeter)

A supplementary, portable chairside device that measures total VSC concentration in ppb. Used for screening and follow-up, but cannot distinguish between individual gases and is less sensitive to methyl mercaptan than laboratory-grade gas chromatography.^[3],[8]

Supplementary assessment: periodontal status and tongue-coating index. Gastrointestinal assessment (e.g. breath testing or endoscopy) is not a routine part of the halitosis work-up and should only be considered when there is an independent clinical suspicion of gastrointestinal disease.

Clinical case vignettes

Fictional teaching example — not an expected patient result.

• Case 1 — classic intraoral: A man with daily morning odour and social withdrawal. Objective assessment and OralChroma support an intraoral cause with thick dorso-posterior tongue coating. Plan: tongue scraper twice daily, mouthwash after individual advice, professional cleaning by dentist/dental hygienist. At follow-up, improvement is seen in odour and measured sulphur compounds.^{[6],[13],[14]}
• Case 2 — periodontal: A woman with generalised stage III periodontitis. Plan: scaling/root planing by dentist/dental hygienist, possibly adjunctive CHX after individual advice, ongoing recall.^[6],[14]
• Case 3 — extraoral, possible systemic cause: A woman with normal oral assessment but strong nasal odour. Mouth and ENT status are assessed first to exclude a local cause. Finding elevated dimethyl sulphide cannot in itself prove a systemic cause. Only if objective halitosis remains unexplained and there is an independent clinical suspicion of hepatic or other systemic disease is the patient referred for relevant medical assessment; a gastroscopy is only included if there are otherwise independent signs of gastrointestinal disease.^[3],[7]
• Case 4 — pseudo-halitosis: A man with long-standing social isolation despite normal objective measurements. Plan: review of measurement data, structured counselling; if fixation and significant distress persist, referral to relevant medical or psychological/psychiatric assessment.^[1],[3],[4]

Treatment: a comprehensive, cause-directed plan

An effective treatment plan should systematically address the verified root cause and not merely mask the odour. Treatment is structured in three clinical steps, informed by the international consensus.^[3],[14]

Step 1 — mechanical biofilm disruption

• Targeted tongue debridement: Ordinary toothbrushing is insufficient for the posterior tongue anatomy. Clinical studies show that cleaning the posterior tongue dorsum twice daily with a dedicated tongue scraper significantly reduces VSC levels.^[13],[14]
• Professional periodontal treatment: For periodontitis, non-surgical periodontal therapy (scaling and root planing) is performed by a dentist or dental hygienist to remove the subgingival anaerobic biofilm and close deep pockets.^[6],[14]

Step 2 — chemical and micro-ecological antimicrobial therapy

• Synergistic mouthwashes: Randomised studies support formulations combining an antibacterial agent with a VSC-neutralising agent. An antiseptic mouthwash with chlorhexidine (CHX) or cetylpyridinium chloride (CPC) combined with zinc ions can, in selected cases, be used short-term after individual advice; the zinc ions bind directly to sulphur radicals and convert them into non-volatile, odourless zinc compounds. Treatment of underlying gum disease, plaque or dental problems takes place together with a dentist or dental hygienist.^[14],[15]
• Probiotics for the oral microbiome: Probiotics may possibly have a short-term adjunctive effect in some patients, but studies are small and heterogeneous, and long-term effect, optimal strain and treatment duration remain uncertain. Probiotics should therefore not be presented as standard first-line treatment or as documented prevention of relapse.^[14]

Step 3 — multidisciplinary referral pathways

• Dentist/dental hygienist and ENT referral: Treatment of gum disease, plaque, dental problems or tongue coating always takes place together with the patient's dentist or dental hygienist. If oral VSC levels are normal but organoleptic assessment of nasal breath is positive, the patient is referred to ENT for chronic sinusitis/tonsilloliths. Only if there is in addition an independent clinical suspicion of gastrointestinal disease (e.g. a pronounced reflux history) is a targeted gastroenterological assessment offered, which may include a gastroscopy.^[1],[3],[7]
• Psychological support: Patients with persistent pseudo-halitosis or halitophobia are referred for cognitive behavioural therapy (CBT), as further dental interventions will not resolve the underlying somatic anxiety.^[1],[3],[4]

Treatment matrix (TN1–TN5)

• TN1 — all patients: information, optimised oral hygiene, mechanical tongue cleaning, possibly zinc/CHX/CPC mouthwash.^{[13],[14],[15]}
• TN2 — intraoral halitosis: professional cleaning, periodontal treatment, management of caries and insufficient fillings.^[6],[14]
• TN3 — extraoral halitosis: ENT referral for sinusitis/tonsilloliths; internal medicine for systemic disease (diabetes, liver, kidney). Gastrointestinal assessment (e.g. gastroscopy) is offered only if there is an independent suspicion of gastrointestinal disease — not on the basis of bad breath alone.^[3],[7]
• TN4 — pseudo-halitosis: review of measurement results, basic oral hygiene and reassurance.^[1],[3]
• TN5 — halitophobia: referral to psychologist/psychiatrist and CBT.^[1],[3]

Prognosis

Halitosis can often improve when a verified intraoral cause is treated. Effect and time course vary. If symptoms persist despite relevant oral and dental assessment, the diagnosis and possible causes should be reconsidered.^[13],[14]

Extraoral halitosis depends on the treatment response of the underlying ENT, GI or systemic disease, if such a cause has been independently confirmed.^[1],[3],[7]

Olfactory reference disorder/halitophobia requires multidisciplinary follow-up. Objective measurement data is an important element here — both for patient reassurance and to avoid unnecessary repeated dental interventions — but it does not replace a medical or psychological/psychiatric assessment.^[1],[3],[9]

Book your halitosis analysis